Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 4
1970 2
1971 1
1972 1
1973 5
1974 3
1975 2
1976 5
1977 1
1978 5
1979 2
1980 2
1981 2
1984 1
1985 2
1986 2
1987 2
1988 3
1989 1
1990 5
1991 12
1992 21
1993 8
1994 9
1995 17
1996 14
1997 8
1998 14
1999 10
2000 11
2001 16
2002 12
2003 8
2004 11
2005 13
2006 13
2007 10
2008 14
2009 12
2010 15
2011 12
2012 18
2013 14
2014 11
2015 17
2016 11
2017 10
2018 15
2019 9
2020 5
2021 3
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

399 results

Results by year

Filters applied: . Clear all
Page 1
Designer drugs: a medicinal chemistry perspective (II).
Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA. Carroll FI, et al. Ann N Y Acad Sci. 2021 Apr;1489(1):48-77. doi: 10.1111/nyas.14349. Epub 2020 May 12. Ann N Y Acad Sci. 2021. PMID: 32396701 Review.
Molecular mechanism of biased signaling at the kappa opioid receptor.
El Daibani A, Paggi JM, Kim K, Laloudakis YD, Popov P, Bernhard SM, Krumm BE, Olsen RHJ, Diberto J, Carroll FI, Katritch V, Wünsch B, Dror RO, Che T. El Daibani A, et al. Among authors: carroll fi. Nat Commun. 2023 Mar 11;14(1):1338. doi: 10.1038/s41467-023-37041-7. Nat Commun. 2023. PMID: 36906681 Free PMC article.
Development of κ opioid receptor antagonists.
Carroll FI, Carlezon WA Jr. Carroll FI, et al. J Med Chem. 2013 Mar 28;56(6):2178-95. doi: 10.1021/jm301783x. Epub 2013 Feb 14. J Med Chem. 2013. PMID: 23360448 Free PMC article. Review.
Designer drugs: a medicinal chemistry perspective.
Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA. Carroll FI, et al. Ann N Y Acad Sci. 2012 Feb;1248:18-38. doi: 10.1111/j.1749-6632.2011.06199.x. Epub 2011 Nov 17. Ann N Y Acad Sci. 2012. PMID: 22092008 Review.
Epibatidine structure-activity relationships.
Carroll FI. Carroll FI. Bioorg Med Chem Lett. 2004 Apr 19;14(8):1889-96. doi: 10.1016/j.bmcl.2004.02.007. Bioorg Med Chem Lett. 2004. PMID: 15050621 Review.
Metabolism of certain commonly used barbiturates.
Freudenthal RI, Carroll FI. Freudenthal RI, et al. Among authors: carroll fi. Drug Metab Rev. 1973;2(2):265-78. doi: 10.3109/03602537409030012. Drug Metab Rev. 1973. PMID: 4604760 Review. No abstract available.
Nanobody-enabled monitoring of kappa opioid receptor states.
Che T, English J, Krumm BE, Kim K, Pardon E, Olsen RHJ, Wang S, Zhang S, Diberto JF, Sciaky N, Carroll FI, Steyaert J, Wacker D, Roth BL. Che T, et al. Among authors: carroll fi. Nat Commun. 2020 Mar 2;11(1):1145. doi: 10.1038/s41467-020-14889-7. Nat Commun. 2020. PMID: 32123179 Free PMC article.
399 results